Ben-Gurion University researchers develop innovative biosensor, team up with Israeli biotech company OncoHost in bid for FDA approval

Weizmann Institute neuroimmunologist bucked convention to prove that brain is not isolated from immune system, leading to possible therapies to treat Alzheimer's and other diseases

Researchers say longest reported infection underscores importance of protecting vulnerable people from coronavirus, with virus found to mutate during persistent infections

Company's BV blood test to distinguish between bacterial and viral infections recently cleared by FDA; investors include Hong Kong's Horizons Ventures